References
- Pickford H A, Swensen S J, Utz J P. The thoracic cross-sectional imaging of amyloidosis. Am J Roent 1997; 168: 351–355
- Tada S, Lida M, Yao T, Kawakubo K, Yao T, Fuchigami T, Okada M, Fujishima M. Gastrointestinal amyloi-dosis: radiological features by chemical types. Radiology 1994; 190: 37–42
- Dubrey S W, Cha K, Skinner M, LaValley M, Falk R H. Familial and primary cardiac amyloidosis: echocardiographically similate diseases with distinctly different clinical outcomes. Heart 1997; 78: 74–82
- Fattori Rocchi R. G, Celletti F, Bertaccini P, Rapezzi C, Gavelli G. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and systematic hypertrophic cardiomyopathy. Am Heart J 1998; 136: 824–830
- Lee V W, Antonacci V, Fuller J D, Tillak S, Cooley T P. Sequential thallium and gallium scans for the diagnosis of intracranial lesions among patients with AIDS. Radiology 1999; 211: 507–512
- Krishnamurthy and Krishnamurthy G T. Nuclear hepatology: Where is it heading now?. J Nucl Med 1988; 29: 1144–1149
- Lee V W, Calderone A, Falk R H, Rubinow A, Cohen A S. Comparison of Tc99m pyrophosphate and methyl-ene diphosphate for detection of soft tissue amyloidosis. Radiology 1983; 148: 239–242
- Lee V W, Ngnai S., Skinner M, Cohen A S. Renal amyloidosis: evaluation using gallium scan. Clin Nuclear Med 1986; 111: 642–646
- Nelson S R, Hawkins P N, Richardson S, Lavender J P, Sethi D, Glower P E, Pugh C W. Imaging of hemodialy-sis-associated amyloidosis with 1–123 serum amyloid P component. Lancer 1991; 338: 335–339
- Floege J, Ehlerding G. Beta-2-microglobulin-a∼-sociated amyloidosis. Nephron 1996; 72: 9–26
- Dewanjee M K. The chemistry of Tc-99m labeled radiopharmaceuticals. Semin NucI Med 1990; 20: 5–27
- Nunn A D. Radiopharmaceutical for imaging myocar-dial perfusion. Semin NucI Med 1990; 20: 111–118